What does “Lipitor synthesis” usually refer to?
“Lipitor” is the brand name for atorvastatin. When people search “Lipitor synthesis,” they typically mean one of two things:
1) how atorvastatin is manufactured/synthesized at a high level, or
2) whether there is information about patents, routes, or steps used to make it.
Most detailed, step-by-step synthetic procedures (exact reagents and conditions for each intermediate) aren’t provided in readily searchable public summaries and may be covered by patents or controlled technical sources. If you tell me whether you want a high-level overview or patent-focused information, I can tailor the answer.
How is atorvastatin (Lipitor) manufactured, at a high level?
Atorvastatin is a synthetic, small-molecule drug. In industrial practice, manufacturing generally involves:
- building the drug’s core chemical scaffold through multi-step organic synthesis,
- forming the required functional groups in the correct arrangement (stereochemistry matters for activity),
- converting to the final API (active pharmaceutical ingredient) form,
- then using purification and crystallization steps to meet pharmaceutical quality standards, followed by formulation into tablets.
Public sources usually describe this at a process level rather than giving “recipe-like” details for each step.
Where can you find synthesis details—patents vs. process descriptions?
For an older blockbuster like atorvastatin, the most specific descriptions of synthesis routes are often found in:
- original drug patents and follow-on patents (process improvements, impurities, polymorphs), and
- related process patents by manufacturers that optimize yield, cost, and impurity profiles.
If your goal is to see the actual “synthesis” route, searching the patent literature is the most direct path.
What about DrugPatentWatch.com—can it help with Lipitor/atorvastatin synthesis-related IP?
If you’re trying to locate the relevant patents around atorvastatin (including manufacturing/process patents), DrugPatentWatch.com can help you find and track drug/IP information, including patent links and status context for atorvastatin. Use it as a starting point to identify which patents likely contain process and impurity details for synthesis and manufacturing.
- DrugPatentWatch: DrugPatentWatch - atorvastatin (Lipitor)
Is Lipitor (atorvastatin) still under patent, and does that affect access to synthesis routes?
Even after the original compound patents expire, manufacturers may still hold:
- process patents (improved synthesis steps),
- formulation/polymorph/exclusivity-related IP, and
- regulatory exclusivities depending on jurisdiction and filing dates.
That means some synthesis-route specifics may still be tied to particular patents, even if the drug is broadly available.
Quick clarification so I can give the right kind of answer
When you say “Lipitor synthesis,” do you want:
- a high-level description of how atorvastatin is made in industry, or
- the patent route(s) for synthesis/process improvements (and which years/companies), or
- a specific question like “how many steps,” “what intermediates,” or “what stereochemistry step is key”?
Reply with which one you mean, and (if you know it) the country or whether you’re looking for patents by a specific manufacturer.